Evidence-Based Medicine Guidelines
Mitoxantrone for multiple sclerosis
There's more to see -- the rest of this topic is available only to subscribers.
Citation
"Mitoxantrone for Multiple Sclerosis." Evidence-Based Medicine Guidelines, Duodecim Medical Publications Limited, 2024. Evidence Central, evidence.unboundmedicine.com/evidence/view/EBMG/451419/all/Mitoxantrone_for_multiple_sclerosis.
Mitoxantrone for multiple sclerosis. Evidence-Based Medicine Guidelines. Duodecim Medical Publications Limited; 2024. https://evidence.unboundmedicine.com/evidence/view/EBMG/451419/all/Mitoxantrone_for_multiple_sclerosis. Accessed January 30, 2025.
Mitoxantrone for multiple sclerosis. (2024). In Evidence-Based Medicine Guidelines. Duodecim Medical Publications Limited. https://evidence.unboundmedicine.com/evidence/view/EBMG/451419/all/Mitoxantrone_for_multiple_sclerosis
Mitoxantrone for Multiple Sclerosis [Internet]. In: Evidence-Based Medicine Guidelines. Duodecim Medical Publications Limited; 2024. [cited 2025 January 30]. Available from: https://evidence.unboundmedicine.com/evidence/view/EBMG/451419/all/Mitoxantrone_for_multiple_sclerosis.
* Article titles in AMA citation format should be in sentence-case
TY - ELEC
T1 - Mitoxantrone for multiple sclerosis
ID - 451419
BT - Evidence-Based Medicine Guidelines
UR - https://evidence.unboundmedicine.com/evidence/view/EBMG/451419/all/Mitoxantrone_for_multiple_sclerosis
PB - Duodecim Medical Publications Limited
DB - Evidence Central
DP - Unbound Medicine
ER -
